Page last updated: 2024-08-21

indole-3-carbaldehyde and Hormone-Dependent Neoplasms

indole-3-carbaldehyde has been researched along with Hormone-Dependent Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gastpar, R; Goldbrunner, M; Marko, D; von Angerer, E1
Chen, HY; Chen, LR; Hsiao, PW; Ke, FC; Lin, EH; Lin, FM; Tsai, MJ1

Other Studies

2 other study(ies) available for indole-3-carbaldehyde and Hormone-Dependent Neoplasms

ArticleYear
Methoxy-substituted 3-formyl-2-phenylindoles inhibit tubulin polymerization.
    Journal of medicinal chemistry, 1998, Dec-03, Volume: 41, Issue:25

    Topics: Animals; Antineoplastic Agents; Biopolymers; Brain; Breast Neoplasms; Cattle; Colchicine; Drug Screening Assays, Antitumor; Female; Humans; Indoles; Inhibitory Concentration 50; Microscopy, Fluorescence; Neoplasms, Hormone-Dependent; Protein Binding; Structure-Activity Relationship; Tubulin; Tubulin Modulators; Tumor Cells, Cultured

1998
Compounds from Wedelia chinensis synergistically suppress androgen activity and growth in prostate cancer cells.
    Carcinogenesis, 2007, Volume: 28, Issue:12

    Topics: Androgen Antagonists; Androgen Receptor Antagonists; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apigenin; Cell Line, Tumor; Cell Proliferation; Coumarins; Drug Synergism; Humans; Indoles; Luteolin; Male; Neoplasms, Hormone-Dependent; Plant Extracts; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Wedelia

2007